DocDollars

Fidia Pharma USA Inc.

NJ · United States · Reporting entity ID 100000005682

Total reported 2019–2025
$1.11M
#1,267 of 2,960 reporting companies — 0% of all reported industry payments
$355K in general payments across 15,481 records, plus $755K in research funding across 57 records.

How it breaks down

General payments $354,797
Research funding $754,897

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Fidia Pharma USA Inc. reported $1.11M to US doctors and teaching hospitals from 2019 to 2025, ranking #1,267 of 2,960 reporting companies. 68% of that was research funding and 32% general payments such as consulting, speaking, food and travel. 15,481 general payment records and 57 research records were filed.

Common questions about Fidia Pharma USA Inc.

How much has Fidia Pharma USA Inc. paid US doctors?

Fidia Pharma USA Inc. reported $1,109,694 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $354,797 in general payments, $754,897 in research funding.

How does Fidia Pharma USA Inc. rank among drug and device companies?

It ranks #1,267 of 2,960 reporting entities by total reported value, about 0% of all industry payments in the dataset.

Does a payment from Fidia Pharma USA Inc. mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.